Recent years have witnessed remarkable advancements in the management of muscular dystrophy. Experts are actively exploring innovative strategies that hold promise for ameliorating the lives of individuals stricken by this progressive illness. Drug development have emerged as particularly effective directions for treating the underlying causes of m